Three Symposia, Three Years of Fellows, One Mission: Medscape Oncology at ASCO 2026
May 14, 2026 | #ASCO26 #medscapeoncology, MedEd
Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) with another ambitious oncology program.
Three Symposia at the Hilton Chicago
- The Reality of Care for HER2-Mutated Advanced NSCLC: Closing Community Gaps — Saturday, May 30, 6:15–7:45 PM CT, International Ballroom South. Supported by Bayer.
- Redefining the Patient Journey: The Promise and Practice in NTRK Fusion-Positive Cancers — Sunday, May 31, 6:30–8:00 PM CT, International Ballroom South. Supported by Bayer.
- A Case-Based Guide for CD38-Targeted Monoclonal Antibody Therapy in the Treatment of Multiple Myeloma — Sunday, May 31, 6:30–7:30 PM CT, International Ballroom North. Supported by Sanofi, in partnership with the International Myeloma Foundation.
Online Poster
Medscape Oncology will also be presenting outcomes research as an e-poster: The Impact of Online CME on Addressing Clinical Decision-Making for Immunotherapy in Advanced Squamous NSCLC. Authors: Michelle A. Worst, PharmD, BCOP, MBA, CHCP; Andrew Small; Amy Furedy, RN, OCN; Charu Aggarwal, MD, MPH; Sandip Patel, MD
ASCO Fellows, Year Three
For the third consecutive year, Medscape Oncology is supporting a cohort of Fellows to attend ASCO. Fellows will spend time on the booth in focus groups, go hands-on with Medscape AI and the new medical simulation solution, Clinical Readiness Studio as well as engaging with faculty across the program.
“There is no better time to understand what oncology clinicians actually need than at the start of their specialist careers. Our Fellows tell us where the evidence gaps are, where the tools fall short, and what the next generation expects from medical education. That insight is irreplaceable, and it directly shapes what we build and what we publish. Alongside the symposia and Medscape AI, the Fellows program is central to why we show up at ASCO the way we do,” said Chris Hoffman, Chief Strategy Officer, Medscape Education.
Medscape AI on the Booth
Medscape AI represents a new generation of clinical intelligence and research tools, drawing exclusively on a clinically validated knowledge base of expert-authored content, peer-reviewed journals, and rigorously vetted medical sources, with every response traceable to verifiable citations. Oncology is the most-queried specialty on Medscape AI, with breast cancer and lymphoma topping the list. A recent analysis of platform queries also found that diagnosis support and treatment decisions account for half of all physician queries across specialties.
An Indispensable Resource for Oncologists
Medscape has been delivering oncology education, medical information, and clinical tools for over 30 years. In a recent survey of hem/onc members, 79% recognised it as an indispensable resource, 78% would recommend it to colleagues, and 75% call it their preferred CME website. The trust is there. ASCO 2026 is where we put it to work.
Find the team at Booth #10099 or reach out to Jelena Spyropoulos at jspyropoulos@medscape.net.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Looking Ahead: Transparency, Impact, and Instructional Design at CMEpalooza Spring 2025
Tomorrow at 2 PM ET, join Medscape for a thought-provoking Afternoon Snack Session at CMEpalooza Spring 2025, titled “Reverse Planning with Forward Thinking.” This session will spotlight how clear communication…
Vaccines Are the Most Impactful Innovation in Health Equity
As deadly as the measles outbreak in west Texas and New Mexico is the spread of vaccine conspiracy theories and misinformation. According to KFF research from November 2024, childhood vaccination…
Collaboration Across Healthcare is the Path Forward
How do we impress upon women that they need to prioritize their own health before providing for the people who need them? A leader in medical oncology has a few…
Medscape at ESCMID 2025: Advancing Infectious Disease Education
Medscape, a global leader in infectious disease education, continues its commitment to advancing knowledge in the field. With 1.47 million ID learners in 2024, the Medscape team will travel to…
The future of heart health with AI-powered devices and treatment approaches
Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular disorders. AI is no longer futuristic, it’s a real-world tool, transforming patient care and…
Medscape at ACC 2025: From Taking the Pulse to Getting to the Heart of It
The Medscape team is back in Chicago for the much-anticipated ACC 2025 conference, March 29-31, bringing an array of engaging educational booth highlights, interactive symposia, scientific posters, and more for…
Michelle Worst Honored With 2025 HOPA Volunteer Award
Medscape is proud to highlight Michelle A. Worst, PharmD, BCOP, MBA, CHCP, Senior Director and Team Lead of Clinical Strategy in Hematology/Oncology, for her well-deserved recognition as the recipient of…
Innovations in Women’s Health Coalition Launches New Global Efforts
Medscape Education, the leader in continuing medical education for healthcare professionals, is extending its commitment to closing gaps in women’s health by expanding the efforts of its Innovations in Women’s…
The Only Way We Can Go is Up: Improving Screening and Management of Female Cancers
One of the toughest challenges of educating many African women about female cancers and disease prevention is overcoming cultural biases, as well as shame, stigma, and misinformation. Here’s how two…
Medscape’s Impact on Women’s Health Education: Key Publications at ISSWSH 2025 & Beyond
Just in time for Women’s History Month and International Women’s Day on March 8th, Medscape is proud to showcase its dedication to advancing women’s health education. Sara Thorpe, MPH, Director,…